TrialAIDS (London, England)2008

Increased soluble vascular cell adhesion molecule-1 plasma levels and soluble intercellular adhesion molecule-1 during antiretroviral therapy interruption and retention of elevated soluble vascular cellular adhesion molecule-1 levels following resumption of antiretroviral therapy.

Emmanouil Papasavvas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.